1. 1061PMolecular screening in advanced cancer patients with head and neck cancers: A retrospective analysis of the MOSCATO-01 trial. (23rd October 2018) Authors: Houessinon, A; Verlingue, L; Hollebecque, A; Even, C; Lacroix, L; Postel-Vinay, S; Varga, A; El Dakdouki, Y; Balheda, R; Michot, J-M; Gazzah, A; Marabelle, A; Michiels, S; Rouleau, E; Breuskin, I; de Baere, T; Angevin, E; Scoazec, J-Y; Soria, J-C; Massard, C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1206PIncidence of immune related adverse events in patients 70 years old treated with anti-PD-(L)1 therapy. (23rd October 2018) Authors: Baldini, C; Martin-Romano, P; Voisin, A-L; Danlos, F X; Champiat, S; Laghouati, S; Kfouri, M; Vincent, H; Nagera, C; Postel-Vinay, S; Varga, A; Ribrag, V; Besse, B; Hollebecque, A; Lambotte, O; Michot, J-M; Soria, J-C; Massard, C; Marabelle, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1843PMolecular alterations and matched treatment in older patients: Results from the MOSCATO 01 trial. (23rd October 2018) Authors: Vuagnat, P; Baldini, C; Verlingue, L; Martin Romano, P; Varga, A; Hollebecque, A; Postel-Vinay, S; Gazzah, A; Bahleda, R; Marabelle, A; Ribrag, V; Champiat, S; Michot, J-M; Soria, J-C; Massard, C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 1885PPrecision medicine for patients with rare cancers: An effective strategy within the prospective MOSCATO trial. (23rd October 2018) Authors: Abdelshafy, M; El Dakdouki, Y; Verlingue, L; Hollebecque, A; Lacroix, L; Postel-Vinay, S; Varga, A; Balheda, R; Michot, J-M; Marabelle, A; Rouleau, E; Solary, E; de Baere, T; Angevin, E; Ribrag, V; Michiels, S; André, F; Scoazec, J-Y; Soria, J-C; Massard, C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 26PA combination of resistance mechanisms is frequent in non-small cell lung cancer (NSCLC) that progressed to EGFR tyrosine kinase inhibitors (TKIs). (7th November 2019) Authors: Enrico, D H; Lacroix, L; Rouleau, E; Scoazec, J-Y; Loriot, Y; Tselikas, L; Jovelet, C; Planchard, D; Gazzah, A; Mezquita, L; Ngo, M; Michiels, S; Maillard, A; Massard, C; Facchinetti, F; Soria, J-C; André, F; Vassal, G; Friboulet, L; Besse, B Journal: Annals of oncology Issue: Volume 30(2019)Supplement 7 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 296PApplicability of the lung immune prognostic index (LIPI) to metastatic triple negative breast cancer (mTNBC) patients treated with immune checkpoint targeted monoclonal antibodies (ICT mAbs). (23rd October 2018) Authors: Vozy, A; Simonaggio, A; Auclin, E; Mezquita, L; Baldini, C; Martin-Romano, P; Pistilli, B; Gazzah, A; Bahleda, R; Ribrag, V; Postel-Vinay, S; Champiat, S; Soria, J-C; André, F; Massard, C; Besse, B; Delaloge, S; Varga, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 31PMATCH-R development of preclinical models from patient with acquired resistance to targeted therapy. (16th September 2018) Authors: Bigot, L; Deas, O; Lang, G; André, F; Caro, S; Friboulet, L; Loriot, Y; Judde, J-G; Besse, B; Soria, J-C Journal: Annals of oncology Issue: Volume 29:Number 6(2018)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 439PProspective validation of prognostic scores to improve patient selection for immuno-oncology trials. (23rd October 2018) Authors: Massard, C; Segal, N H; Cho, D C; Papadimitrakopoulou, V A; Rizvi, N A; Cho, B C; Yu, L; Yang, H; Hsieh, H-J; Zhang, J; Zhao, W; Gao, G; Guo, X; Abdullah, S; Englert, J; Soria, J-C; Dar, M; Roskos, L; Ferte, C; Antonia, S J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 59OPreliminary results on mechanisms of resistance to ALK inhibitors: A prospective cohort from the MATCH-R study. (16th September 2018) Authors: Recondo, G; Mezquita, L; Bigot, L; Galissant, J; Frias, R L; André, F; Massard, C; Soria, J-C; Besse, B; Friboulet, L Journal: Annals of oncology Issue: Volume 29:Number 6(2018)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 92PDetection of PIK3CA mutation by circulating DNA during chemotherapy: A tool to identify hard-to-treat metastatic breast cancers. (7th November 2019) Authors: Mosele, F; Lusque, A; Tran Dien, A; Droin, N; Le Tourneau, C; Sablin, M P; Lacroix, L; Miran, I; Jovelet, C; Bieche, I; Soria, J-C; Bertucci, F; Bonnefoi, H; Campone, M; Dalenc, F; Bachelot, T; Jacquet, A; Jimenez, M; André, F Journal: Annals of oncology Issue: Volume 30(2019)Supplement 7 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗